PubMed:32472459 / 1006-1200
Annnotations
LitCovid-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T15 | 12-25 | CHEBI:35718 | denotes | antimalarials |
T16 | 12-25 | CHEBI:35718 | denotes | antimalarials |
T17 | 27-42 | CHEBI:50858 | denotes | corticosteroids |
T18 | 27-42 | CHEBI:50858 | denotes | corticosteroids |
T19 | 71-80 | CHEBI:36357 | denotes | molecules |
T20 | 71-80 | CHEBI:36357 | denotes | molecules |
T21 | 95-101 | UBERON:0001969 | denotes | plasma |
T22 | 135-140 | CHEBI:23888 | denotes | drugs |
T23 | 135-140 | CHEBI:23888 | denotes | drugs |
T24 | 185-193 | SP_7 | denotes | COVID-19 |
Inflammaging
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T7 | 0-194 | Sentence | denotes | Antivirals, antimalarials, corticosteroids, biotechnological and small molecules, convalescent plasma and anticoagulants are among the drugs proposed for the treatment or in tested for COVID-19. |
T7 | 0-194 | Sentence | denotes | Antivirals, antimalarials, corticosteroids, biotechnological and small molecules, convalescent plasma and anticoagulants are among the drugs proposed for the treatment or in tested for COVID-19. |